0001209191-19-046444.txt : 20190819
0001209191-19-046444.hdr.sgml : 20190819
20190819061224
ACCESSION NUMBER: 0001209191-19-046444
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190815
FILED AS OF DATE: 20190819
DATE AS OF CHANGE: 20190819
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cassella James V
CENTRAL INDEX KEY: 0001353528
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36310
FILM NUMBER: 191034793
MAIL ADDRESS:
STREET 1: 2091 STIERLIN COURT
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONCERT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001367920
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 65 HAYDEN AVENUE
STREET 2: SUITE 3000N
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-860-0045
MAIL ADDRESS:
STREET 1: 65 HAYDEN AVENUE
STREET 2: SUITE 3000N
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: CONCERT PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060628
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-08-15
0
0001367920
CONCERT PHARMACEUTICALS, INC.
CNCE
0001353528
Cassella James V
C/O CONCERT PHARMACEUTICALS, INC.
65 HAYDEN AVENUE, SUITE 3000N
LEXINGTON
MA
02421
0
1
0
0
Chief Development Officer
Common Stock
2019-08-15
4
A
0
31100
A
52265
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Common Stock of the Issuer.
35% of the RSUs granted to Mr. Cassella will vest on August 15, 2020, and the remaining 65% of the RSUs will vest on August 15, 2021. The number above represents the maximum number of shares that may be delivered pursuant to the award.
Not applicable.
/s/ Nancy Stuart as attorney-in-fact for James V. Cassella
2019-08-19